BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23937247)

  • 1. The selectivity and potency of the new PDE5 inhibitor TPN729MA.
    Wang Z; Zhu D; Yang X; Li J; Jiang X; Tian G; Terrett NK; Jin J; Wu H; He Q; Yang B; Shen J
    J Sex Med; 2013 Nov; 10(11):2790-7. PubMed ID: 23937247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction.
    Kotera J; Mochida H; Inoue H; Noto T; Fujishige K; Sasaki T; Kobayashi T; Kojima K; Yee S; Yamada Y; Kikkawa K; Omori K
    J Urol; 2012 Aug; 188(2):668-74. PubMed ID: 22704456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.
    Wang R; Burnett AL; Heller WH; Omori K; Kotera J; Kikkawa K; Yee S; Day WW; DiDonato K; Peterson CA
    J Sex Med; 2012 Aug; 9(8):2122-9. PubMed ID: 22759639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
    Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
    González-Corrochano R; La Fuente J; Cuevas P; Fernández A; Chen M; Sáenz de Tejada I; Angulo J
    Br J Pharmacol; 2013 May; 169(2):449-61. PubMed ID: 23441682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study.
    Huang YY; Li Z; Cai YH; Feng LJ; Wu Y; Li X; Luo HB
    J Chem Inf Model; 2013 Nov; 53(11):3044-53. PubMed ID: 24180640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of sildenafil modified the impaired VEGF system and improved the erectile function in rats with diabetic erectile dysfunction.
    Liu G; Sun X; Dai Y; Zheng F; Wang D; Huang Y; Bian J; Deng C
    J Sex Med; 2010 Dec; 7(12):3868-78. PubMed ID: 20487237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
    Martínez-Salamanca JI; La Fuente JM; Cardoso J; Fernández A; Cuevas P; Wright HM; Angulo J
    J Sex Med; 2014 May; 11(5):1182-92. PubMed ID: 24877179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to phosphodiesterase type 5 inhibitors stimulates aromatase expression in human adipocytes in vitro.
    Aversa A; Caprio M; Antelmi A; Armani A; Brama M; Greco EA; Francomano D; Calanchini M; Spera G; Di Luigi L; Rosano GM; Lenzi A; Migliaccio S; Fabbri A
    J Sex Med; 2011 Mar; 8(3):696-704. PubMed ID: 21176111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
    J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil citrate improves erectile function after castration in a rat model.
    Mulhall JP; Verma N; Deveci S; Tal R; Kobylarz K; Müller A
    BJU Int; 2014 Apr; 113(4):656-61. PubMed ID: 23773301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries.
    Kruuse C; Gupta S; Nilsson E; Kruse L; Edvinsson L
    Eur J Pharmacol; 2012 Jan; 674(2-3):345-51. PubMed ID: 22094063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase type 5 inhibitors facilitate noncontact erections in male rats: site of action in the brain and mechanism of action.
    Sanna F; Succu S; Boi A; Melis MR; Argiolas A
    J Sex Med; 2009 Oct; 6(10):2680-9. PubMed ID: 19678884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System.
    Salmasi A; Lee GT; Patel N; Goyal R; Dinizo M; Kwon YS; Modi PK; Faiena I; Kim HJ; Lee N; Hannan JL; Kohn J; Kim IY
    J Sex Med; 2016 Dec; 13(12):1834-1843. PubMed ID: 27843073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes.
    Zhang XH; Filippi S; Morelli A; Vignozzi L; Luconi M; Donati S; Forti G; Maggi M
    J Sex Med; 2006 Mar; 3(2):253-64; discussion 264-5, author reply 265-6. PubMed ID: 16490018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in rats.
    Küçük A; Yucel M; Erkasap N; Tosun M; Koken T; Ozkurt M; Erkasap S
    Mol Biol Rep; 2012 Oct; 39(10):9775-82. PubMed ID: 22736111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.
    Montorsi F; Corbin J; Phillips S
    J Sex Med; 2004 Nov; 1(3):322-36. PubMed ID: 16422964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.